SYNERGISM OF CISPLATIN AND MITOMYCIN-C IN SENSITIVE AND RESISTANT CELL SUBPOPULATIONS OF A TUMOR-MODEL

被引：19

作者：

DURAND, RE

机构：

来源：

INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 05期

关键词：

D O I：

10.1002/ijc.2910440528

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：911 / 917

页数：7

共 20 条

[1] PHASE-II RANDOMIZED TRIAL OF CISPLATIN CHEMOTHERAPY REGIMENS IN THE TREATMENT OF RECURRENT OR METASTATIC SQUAMOUS-CELL CANCER OF THE CERVIX - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

ALBERTS, DS ;

KRONMAL, R ;

BAKER, LH ;

STOCKNOVACK, DL ;

SURWIT, EA ;

BOUTSELIS, JG ;

HANNIGAN, EV .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) :1791-1795

[2]

CARTER SK, 1979, MITOMYCIN C CURRENT

[3]

CHAHINIAN AP, 1984, CANCER RES, V44, P1688

[4] QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].

CHOU, TC ;

TALALAY, P .

ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55

[5]

DURAND RE, 1987, CANCER TREAT REP, V71, P673

[6]

DURAND RE, 1986, JNCI-J NATL CANCER I, V77, P247

[7] DISTRIBUTION AND ACTIVITY OF ANTINEOPLASTIC DRUGS IN A TUMOR-MODEL [J].

DURAND, RE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) :146-152

[8] CELL-CYCLE KINETICS IN AN INVITRO TUMOR MODEL [J].

DURAND, RE .

CELL AND TISSUE KINETICS, 1976, 9 (05) :403-412

[9]

DURAND RE, 1986, CANCER RES, V46, P2775

[10]

DURAND RE, 1988, NATL CANCER I MONOGR, V6, P95

← 1 2 →